| Jose M Negron-soto, MD | |
|
111 Brewster Street, Pawtucket, RI 02860-4400 | |
| (401) 729-2339 | |
| Not Available |
| Full Name | Jose M Negron-soto |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 111 Brewster Street, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083635437 | NPI | - | NPPES |
| 110086874A | Medicaid | MA | |
| JN77480 | Medicaid | RI | |
| 001302601 | Other | RI | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 35.087546 (Ohio) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | MD13104 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Doctors Hospital Of Sarasota | Sarasota, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tower Imaging Llc | 2860470077 | 107 |
| Intercoastal Medical Group Inc | 6305730912 | 165 |
| Mori Bean And Brooks Inc | 8820077878 | 633 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Medical Technology Transfer Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104947217 PECOS PAC ID: 1658265079 Enrollment ID: O20040209000360 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Intercoastal Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578537767 PECOS PAC ID: 6305730912 Enrollment ID: O20040212000600 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Tower Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467654244 PECOS PAC ID: 2860470077 Enrollment ID: O20040713000446 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Mori Bean And Brooks Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20040714001317 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Advanced Imaging Of Port Charlotte Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659365021 PECOS PAC ID: 8123084134 Enrollment ID: O20041201000998 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Elite Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346516853 PECOS PAC ID: 2466496880 Enrollment ID: O20050616000704 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Manatee Memorial Hospital L P |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770505687 PECOS PAC ID: 2062309164 Enrollment ID: O20060221000789 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Rose Radiology Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629162904 PECOS PAC ID: 2961451315 Enrollment ID: O20141022002331 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose M Negron-soto, MD 111 Brewster Street, Wood Bldg #516, Pawtucket, RI 02860-4400 Ph: (401) 729-3481 | Jose M Negron-soto, MD 111 Brewster Street, Pawtucket, RI 02860-4400 Ph: (401) 729-2339 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced the introduction of its Sprint to Meaningful Use solution, specifically designed to help healthcare organizations quickly achieve the objectives of the Health Information Technology for Economic and Clinical Health Act (HITECH Act).
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 1 days ago
Artemio M Manansala, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Pawtucket, RI 02860 Phone: 401-729-2617 | |
Dr. Michael E Jay, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 111 Brewster Street, Pawtucket, RI 02860 Phone: 401-729-2339 | |
Joan C Desantis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Pawtucket, RI 02860 Phone: 401-729-2339 |